Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATE.
Terreaux W, Masson C, Eschard JP, Bardin T, Constantin A, Le Dantec L, Marcelli C, Perdriger A, Scotto Di Fazano C, Wendling D, Sibilia J, Morel J, Salmon JH. Terreaux W, et al. Among authors: perdriger a. Joint Bone Spine. 2018 Jan;85(1):53-57. doi: 10.1016/j.jbspin.2017.01.002. Epub 2017 Jan 20. Joint Bone Spine. 2018. PMID: 28115268
Campylobacter fetus septic arthritis revealing a malignancy.
Rollot K, Albert JD, Werner S, Tattevin P, Cozic I, Perdriger A, Chalès G, Guggenbuhl P. Rollot K, et al. Among authors: perdriger a. Joint Bone Spine. 2004 Jan;71(1):63-5. doi: 10.1016/S1297-319X(03)00094-0. Joint Bone Spine. 2004. PMID: 14769524
Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up.
Gossec L, Le Henanff A, Breban M, Vignon E, Claudepierre P, Devauchelle V, Wendling D, Lespessailles E, Euller-Ziegler L, Sibilia J, Perdriger A, Alexandre C, Dougados M. Gossec L, et al. Among authors: perdriger a. Rheumatology (Oxford). 2006 Jul;45(7):859-62. doi: 10.1093/rheumatology/kel015. Epub 2006 Jan 25. Rheumatology (Oxford). 2006. PMID: 16436489 Clinical Trial.
Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment.
Breban M, Ravaud P, Claudepierre P, Baron G, Henry YD, Hudry C, Euller-Ziegler L, Pham T, Solau-Gervais E, Chary-Valckenaere I, Marcelli C, Perdriger A, Le Loët X, Wendling D, Fautrel B, Fournié B, Combe B, Gaudin P, Jousse S, Mariette X, Baleydier A, Trape G, Dougados M; French Ankylosing Spondylitis Infliximab Network. Breban M, et al. Among authors: perdriger a. Arthritis Rheum. 2008 Jan;58(1):88-97. doi: 10.1002/art.23167. Arthritis Rheum. 2008. PMID: 18163509 Free article. Clinical Trial.
Tocilizumab in refractory adult Still's disease.
Puéchal X, DeBandt M, Berthelot JM, Breban M, Dubost JJ, Fain O, Kahn JE, Lequen L, Longy-Boursier M, Perdriger A, Schaeverbeke T, Toussirot E, Sibilia J; Club Rhumatismes Et Inflammation. Puéchal X, et al. Among authors: perdriger a. Arthritis Care Res (Hoboken). 2011 Jan;63(1):155-9. doi: 10.1002/acr.20319. Arthritis Care Res (Hoboken). 2011. PMID: 20740616 Free article.
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.
Gottenberg JE, Seror R, Miceli-Richard C, Benessiano J, Devauchelle-Pensec V, Dieude P, Dubost JJ, Fauchais AL, Goeb V, Hachulla E, Hatron PY, Larroche C, Le Guern V, Morel J, Perdriger A, Puéchal X, Rist S, Saraux A, Sene D, Sibilia J, Vittecoq O, Nocturne G, Ravaud P, Mariette X. Gottenberg JE, et al. Among authors: perdriger a. PLoS One. 2013 May 24;8(5):e59868. doi: 10.1371/journal.pone.0059868. Print 2013. PLoS One. 2013. PMID: 23717383 Free PMC article.
107 results